World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 December 2012
Main ID:  NCT00681291
Date of registration: 15/05/2008
Primary sponsor: LifeCell
Public title: Strattice in Repair of Inguinal Hernias RING
Scientific title: Prospective, Randomized, Controlled, Third-Party Blinded Multicenter Evaluation of Strattice/LTM in the Repair of Inguinal Hernias
Date of first enrolment: April 2008
Target sample size: 172
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00681291
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Samir Awad, MD, FACS
Address: 
Telephone:
Email:
Affiliation:  Baylor College of Medicine
Name:   Robert Fitzgibbons, MD, FACS
Address: 
Telephone:
Email:
Affiliation:  Creighton University
Name:   Charles Bellows, MD, FACS
Address: 
Telephone:
Email:
Affiliation:  Tulane University School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- adult male

- symptomatic and palpable inguinal hernia

- open, elective, primary unilateral inguinal hernia repair

Exclusion Criteria:

- bilater inguinal hernia repair

- BMI >35

- chronic immunosuppression, active chemo/radiation therapy, uncontrolled diabetes,
severe liver disease or COPD

- chronic prostatitis, orchitis, testicular pain

- local or systemic infection at time of repair

- known collagen disorder

- chronic pain syndrome or under active pain management



Age minimum: 18 Years
Age maximum: N/A
Gender: Male
Health Condition(s) or Problem(s) studied
Hernia, Inguinal
Intervention(s)
Device: Inguinal hernia repair with Strattice
Device: Inguinal hernia repair with Ultrapro
Primary Outcome(s)
Resumption of Activities of Daily Living [Time Frame: Months 3, 6, 12 and 24]
Secondary Outcome(s)
Analgesic consumption [Time Frame: POD 1-10, Month 3]
Hernia recurrence [Time Frame: Months 12 and 24]
Incidence of chronic pain [Time Frame: Month 12]
Postoperative wound events [Time Frame: POD 10 and Month 3]
Quality and severity of pain [Time Frame: POD 10 and Months 3, 6, 12 and 24]
Secondary ID(s)
LFC2007.04.01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history